Effects of dopaminergic agents on visceral pain measured by the mouse writhing test

Archives Internationales de Pharmacodynamie et de Therapie

Volumn 331, Issue 1, 1996, Pages 74-93

  Frussa Filho, R ^a   Rocha, J B T ^b   Conceicao I M ^c   Mello, C F ^b   Pereira, M E ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c INSTITUTO BUTANTAN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ANALGESIC AGENT; APOMORPHINE; BROMOCRIPTINE; COCAINE; DEXAMPHETAMINE; DOMPERIDONE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; NALTREXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG ANTAGONISM; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; VISCERAL PAIN; WRITHING TEST;

EID: 84983721632     PISSN: 00039780     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. ARNT, J., HYTTEL, J. and PERRIGAARD, J. Dopamine D-l agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Europ. J. Pharmacol. 133, 137-145 (1987).
2. ARNT, J., BOGESO, K. P., HYTTEL, J. and MEIER, E. Relative dopamine Dl and D2 receptor affinity and efficacy determine whether dopamine agonists induced hyperactivity or oral stereotypy in rats. Pharmacol. Toxicol. 62, 121-130 (1988).
3. BEN-SRETI, M. M., GONZALEZ, J. P. and SEWELL, R. D. E. Differential effects of SK&F 38393 and LY 141865 on nociception and morphine. Life Sei. 33, 665-668 (1983).
4. BLACKBURN, K. J., FRENCH, P. C. and MERRILLS, R. J. 5-Hydroxytryptamine uptake by rat brain in titro. Life Sei. 6, 1653-1663 (1967).
5. BRAUN, A. R. and CHASE, T. N. Obligatory D1/D2 receptor interaction in the generation of dopamine agonist related behaviours. Europ. J. Pharmacol. 131, 301-306 (1986).
6. CHERNOV, H. I., WILSON, D. E., FOWLER, F. and PLUMMER, A. J. Non-specificity of the mouse writhing test. Arch. int. Phannacodyn. 167, 171-178 (1967).
7. DALY, S. A. and WADDINGTON, J. L. Two directions of dopamine D1/D2 receptor interaction in studies of behavioural regulation: A finding generic to four new, selective dopamine Dl receptor antagonists. Europ. J. Pharmacol. 213, 251-258 (1992).
8. DE FEUDIS, F. V. GABAergic analgesia - A naloxone insensitive system. Pharmacol. Res. Commun. 14, 383-390 (1982).
9. DENNIS, S. G. and MELZACK, R. Effects of cholinergic and dopaminergic agents on pain and morphine analgesia measured by three pain tests. Exp. Neural. 81, 167-176 (1983).
10. DUNAI-KOVACS, Z. and SZéKELY, J. I. Effect of apomorphine on the antinociceptive activity of morphine. Psychopharmacology 53, 65-72 (1977).
11. GEBHART, G. F. and NESS, T. J. Central mechanisms of visceral pain. Canad. J. Physiol. Pharmacol. 69, 627-634 (1991).
12. GONZALEZ, J. P., SEWELL, R. D. E. and SPENCER, P. S. J. Antinociceptive activity of opiates in the presence of the antidepressant agent nomifensine. Neuropharmacology 19, 613-618 (1980).
13. GONZALES-RIOS, R., VLAICULESCU, A., NATAN, L. B., PROTAIS, P. and COSTENTIN, J. Dissociated effects of apomorphine on various nociceptive responses in mice. J. neural Transm. 67, 87-103 (1986).
14. GORLITZ, B. D. and FREI, H. H. Central monoamines and antinociceptive drug action. Europ. J. Pharmacol. 20, 171-180 (1972).
15. HAYASHI, G. and TAKEMORI, A. E. The type of analgesic-receptor interaction involved in certain analgesic assays. Europ. J.'Pharmacol. 16, 63-66 (1971).
16. JACKSON, D. M. and HASHIZUME, M. Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when Dl dopamine receptors are stimulated with SK&F 38393. Psychopharmacology 90, 147-149 (1986).
17. JAVITCH, J. A., BLAUSTEIN, R. O. and SNYDER, S. H. Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Molec. Pharmacol. 26, 35-44 (1984).
18. JENSEN, T. and YAKSH, T. L. Effects of an intrathecal dopamine agonist, apomorphine, on thermal and chemical evoked noxious responses in rats. Brain Res. 296, 285-293 (1984).
19. KAUPPILA, T. and PERTOVAARA, A. Enhancement of morphine-induced analgesia and attenuation of morphine-induced side-effects by cocaine in rats. Pharmacol. Toxicol. 71, 173-178 (1992).
20. KEBABIAN, J. W. and CALNE, D. B. Multiple receptors for dopamine. Nature 227, 93-96 (1979).
21. KIRIRSKY-ROY, J. A., STANDISH, S. M. and TERRY, L. C. Dopamine Dl and D2 receptor antagonists potentiate analgesic and motor effects of morphine. Pharmacol. Biochem. Behav. 32, 717-721 (1989).
22. KUCZENSKI, R. Biochemical actions of amphetamine and other stimulants. In: Creese, I. (Ed.). Stimulants'. Neiirochemical, Behavioral and Clinical Perspectives, pp. 31-61. Raven Press, New York (1983).
23. LIN, M. T., Wu, J. J., CHANDRA, A. and TSAY, B. L. Activation of striatal dopamine receptors induces pain inhibition in rats. J. neural Transm. 51, 213-222 (1981).
24. LIN, Y., MORROW, T. J. and CASEY, K. L. Cocaine: Evidence for CNS analgesic action. Pain Suppl. 4, 548(1987).
25. LIN, Y., MORROW, T. J., KIRITSKY-ROY, J. A., TERRY, L. C. and CASEY, K. L. Cocaine: Evidence for supraspinal, dopamine-mediated, non-opiate analgesia. Brain Res. 479, 306-312 (1989).
26. MAYER, D. J. Endogenous analgesia systems: Neural and behavioral mechanisms. In: Bonica, J. J. (Ed.). Advances in Pain Research and Therapy, pp. 385-410. Raven Press, New York (1979).
27. MICHAEL-TITUS, A., BOUSSELMAME, R. and COSTENTIN, J. Stimulation of dopamine D2 receptors induces an analgesia involving an opioidergic but not enkephalinergic link. Europ. J. Pharmacol. 187, 201-207 (1990).
28. MOORE, K. E. Amphetamines: Biochemical and behavioural actions in animals. In: Iversen, S. D. and Snyder, S. H. (Eds.). Handbook of Psychopharmacology, Vol.11, pp. 41-98. Plenum Press, New York (1978).
29. MORGAN, M. J. and FRANKLIN, K. B. J. Dopamine receptor subtypes and formalin test analgesia. Pharmacol. Biochem. Behav. 40, 317-322 (1991).
30. NOTT, M. W. Potentiation of morphine analgesia by cocaine in mice. Europ. J. Pharmacol. 5, 93-99 (1968).
31. PAALZOW, G. H. M. and PAALZOW, W. L. K. Opposing effects of apomorphine on pain in rats. Evaluation of the dose-response curve. Europ. J. Pharmacol. 88, 27-35 (1983).
32. PYLATUK, K. L. and McNEiLL, J. H. The effects of certain drugs on uptake and release of [3II]noradrenaline in rat whole brain homogenates. Canad. J. Physiol. Pharmacol. 54, 457-468 (1976).
33. ROBERTSON, J., WESTON, R., LEWIS, M. J. and BARASI, S. Evidence for the potentiation of the antinociceptive action of morphine by bromocriptine. Neuropharmacology 20, 1029-1032 (1981).
34. ROOXEY, K. F. and SEWELL, R. D. E. Evaluation of selective actions of dopamine Dl and D2 receptor agonists and antagonists on opioid antinociception. Europ. J. Pharmacol. 168, 329-336 (1989).
35. ROSS, S. B. and RENYI, A. L. Inhibition of uptake of tritiated catecholamines by antidepressants and related drugs. Europ. J. Pharmacol. 2, 181-186 (1967).
36. Ross, S. B. and RENYI, A. L. Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. Europ. J. Pharmacol. 7, 270-277 (1969).
37. SEEMAN, P. and VAN TOL, H. M. Dopamine receptor pharmacology. Trends pharmacol. Sei. 15,264-270(1994).
38. SIBLEY, D. R. and MONSMA, J. J. Molecular biology of dopamine receptors. Trends pharmacol. Sei. 13, 61-69 (1992).
39. STOOF, J. C. and KEBABIAN, J. W. Opposing roles for Dl and D2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294, 366-368 (1981).
40. TRICKLEBANK, M. D., HUTSON, P. H. and CURZON, G. Involvement of dopamine in the antinociceptive response to footshock. Psychopharmacology 82, 185-188 (1984).
41. TULUNAY, F. C., SPARBER, S. B. and TAKEMORI, A. E. The effect of dopaminergic stimulation and blockade on the nociceptive responses in the mice. Europ. J. Pharmacol. 33, 65-70 (1975).
42. TULUNAY, F. C., YANO, I. and TAKEMORI, A. E. The effect of biogenic amine modifiers on morphine analgesia and its antagonism by naloxone. Europ. J. Pharmacol. 35, 285-292 (1976).
43. VAN DER HEYDEN, J. A. M., VENEMA, K. and KORF, J. Biphasic and opposite effects of dopamine and apomorphine on endogenous GABA release in rat substantia nigra. J. Neurochem. 34, 119-125 (1980).
44. VANDERWENDE, C. and SPOERLEIN, M. T. Role of dopaminergic receptors in morphine analgesia and tolerance. Res. Commun, ehem. Pathol. Pharmacol. 5, 35-43 (1973).
45. WADDINGTON, J. L. Behavioural correlates of the action of selective D-l dopamine receptor antagonists. Impact of SCH 23390 and SK&F 83566, and functionally interactive D1:D2 receptor systems. Biochem. Pharmacol. 35, 3661-3667 (1986).
46. Yu, J. H. and SMITH, C. B. Effect of cocaine and desmethylimipramine on the uptake, retention and metabolism of 3H-5-tryptamine in rat brain slices. Pharmacology 15, 242-253 (1977).
47. ZARRINDAST, M. R. and MOGHADDAMPOUR, E. Influences of dopamine agonists and antagonists on baclofen antinociception in mice. Arch. int. Pharmacodyn. 309, 42-50 (1991).
48. ZEMLAN, F. P., CORRIGAN, S. A. and PFAFF, D. W. Noradrenergic and serotonergic mediation of spinal analgesia mechanisms. Europ. J. Pharmacol. 61, 111-124 (1980).